Clinical evaluation of the degree of neoplastic-disease activity was made in accord with current criteria for evaluation of multiple myeloma (such as serum and urine paraprotein levels ...

is characterized by proliferation of a plasma cell clone and subsequent overabundance of monoclonal paraprotein (M protein). [13] ...

This antibody is known by different names, including monoclonal immunoglobulin, monoclonal protein (M-protein), M-spike, or paraprotein. Plasma cells sometimes grow in other, unusual ways that don’t ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein - 3d render animation Multiple myeloma, also known as myeloma, is a type of bone marrow cancer. Bone marrow is the spongy tissue ...

Neurologists, neurology residents and fellows, medical students, social workers, masters in administration, physician assistants, nurse practitioners, nurses and pharmacists. Additionally, Neurology ...

1 Brain and Mind Research Institute, University of Sydney, Sydney, New South Wales, Australia 2 Neuroscience Research Australia & Prince of Wales Clinical School, University of New South Wales, ...

Oncolytic virotherapy represents an innovative and promising approach for the treatment of cancer, including multiple myeloma (MM), a currently incurable plasma cell (PC) neoplasm. Despite the ...

Background: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma liposomes have been linked to MM, ...